PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Evidence-based practice guideline of Chinese herbal medicine for primary open-angle glaucoma (qingfeng -neizhang).

Abstract Primary open angle glaucoma (POAG) is a chronic, progressive optic neuropathy. The aim was to develop an evidence-based clinical practice guideline of Chinese herbal medicine (CHM) for POAG with focus on Chinese medicine pattern differentiation and treatment as well as approved herbal proprietary medicine.
PMID
Related Publications

Chinese herbal medicine for endometriosis.

Chinese herbal medicines for unexplained recurrent miscarriage.

Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.

Chinese herbal medicine for endometriosis.

Chinese herbal medicine for diabetic peripheral neuropathy.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 29595636
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 13
DP  - 2018 Mar
TI  - Evidence-based practice guideline of Chinese herbal medicine for primary
      open-angle glaucoma (qingfeng -neizhang).
PG  - e0126
LID - 10.1097/MD.0000000000010126 [doi]
AB  - BACKGROUND: Primary open angle glaucoma (POAG) is a chronic, progressive optic
      neuropathy. The aim was to develop an evidence-based clinical practice guideline 
      of Chinese herbal medicine (CHM) for POAG with focus on Chinese medicine pattern 
      differentiation and treatment as well as approved herbal proprietary medicine.
      METHODS: The guideline development group involved in various pieces of expertise 
      in contents and methods. Authors searched electronic databases include CNKI, VIP,
      Sino-Med, Wanfang data, PubMed, the Cochrane Library, EMBASE, as well as checked 
      China State Food and Drug Administration (SFDA) from the inception of these
      databases to June 30, 2015. Systematic reviews and randomized controlled trials
      of Chinese herbal medicine treating adults with POAG were evaluated. Risk of bias
      tool in the Cochrane Handbook and evidence strength developed by the GRADE group 
      were applied for the evaluation, and recommendations were based on the findings
      incorporating evidence strength. After several rounds of Expert consensus, the
      final guideline was endorsed by relevant professional committees. RESULTS: CHM
      treatment principle and formulae based on pattern differentiation together with
      approved patent herbal medicines are the main treatments for POAG, and the
      diagnosis and treatment focusing on blood related patterns is the major domain.
      CONCLUSION: CHM therapy alone or combined with other conventional treatment
      reported in clinical studies together with Expert consensus were recommended for 
      clinical practice.
FAU - Yang, Yingxin
AU  - Yang Y
AD  - Department of Ophthalmology, Beijing Traditional Chinese Medicine Hospital,
      Capital Medical University.
FAU - Ma, Qiu-Yan
AU  - Ma QY
AD  - Department of Ophthalmology, Beijing Traditional Chinese Medicine Hospital,
      Capital Medical University.
FAU - Yang, Yue
AU  - Yang Y
AD  - Department of Ophthalmology, Beijing Traditional Chinese Medicine Hospital,
      Capital Medical University.
FAU - He, Yu-Peng
AU  - He YP
AD  - Department of Ophthalmology, Beijing Traditional Chinese Medicine Hospital,
      Capital Medical University.
FAU - Ma, Chao-Ting
AU  - Ma CT
AD  - Department of Ophthalmology, Beijing Traditional Chinese Medicine Hospital,
      Capital Medical University.
FAU - Li, Qiang
AU  - Li Q
AD  - Department of Ophthalmology, Beijing Traditional Chinese Medicine Hospital,
      Capital Medical University.
FAU - Jin, Ming
AU  - Jin M
AD  - Department of Ophthalmology, China-Japan Friendship Hospital.
FAU - Chen, Wei
AU  - Chen W
AD  - Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese
      Medicine, Beijing, China.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Drugs, Chinese Herbal)
SB  - AIM
SB  - IM
MH  - Drugs, Chinese Herbal/*therapeutic use
MH  - Glaucoma, Open-Angle/*drug therapy
MH  - Humans
EDAT- 2018/03/30 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/03/30 06:00
PHST- 2018/03/30 06:00 [entrez]
PHST- 2018/03/30 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - 10.1097/MD.0000000000010126 [doi]
AID - 00005792-201803300-00009 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2018 Mar;97(13):e0126. doi: 10.1097/MD.0000000000010126.